Ulcerative colitis associated with aplastic anemia; a case report

Ali Ghavidel1

  • 1Liver and Gastrointestinal Diseases Research Centre, Tabriz University of Medical Sciences, Imam Reza hospital, East Azerbaijan, Iran.

Anemia is the most common hematologic disorder in patients with ulcerativecolitis (UC). In some cases, normochromic anemia results from the presenceof chronic disease; however blood loss or malabsorption may lead to aniron deficiency anemia with hypochromic appearance. Other rare hematologicmanifestations associated with UC include myelodysplastic syndromes andleukemia. Several investigators have suggested a clinical association betweeninflammatory bowel disease and myelodysplastic syndrome, which may theyshare an immune dysfunction and impairment of T-lymphocytes activities.UC is an inflammatory bowel disease of unknown etiology that mainly affectsthe mucosa of the colon. Immune mechanisms play an important role in UC,and immunogenetic factors have been implicated in the development of thedisease. Aplastic anemia is a bone marrow stem cell disorder characterized byineffective hematopoiesis, leading to pancytopenia. Although aplastic anemiais frequently idiopathic, the immune-mediated suppression of hematopoiesismay be implicated in at least half of patients, since more than half of thesepatients achieve hematological remission in response to immunosuppressivetherapy. We report here a rare case of UC associated with pancytopenia requiringa blood transfusion in which a bone marrow examination showed aplasticanemia. A common pathogenic link between UC and aplastic anemia is suggestedin this patient on the basis of the shared immunologic impairment underlyingboth diseases.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
33
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
32
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
701
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
31